Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Live attenuated varicella vaccine - Beijing Wantai Biopharmaceutical

Next Previous
Drug Profile

Live attenuated varicella vaccine - Beijing Wantai Biopharmaceutical

Alternative Names: Freeze-dried live attenuated varicella vaccine - Beijing Wantai Biopharmaceutical; Lyophilized varicella attenuated live vaccine - Beijing Wantai Biopharmaceutical; VZV 7D

Latest Information Update: 12 Oct 2022

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Beijing Wantai Bio-pharm
  • Class Attenuated vaccines; Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Varicella zoster virus infections

Most Recent Events

  • 10 Oct 2022 No development reported - Phase-II for Varicella zoster virus infections (In children, Prevention) in China (unspecified route)
  • 31 Jul 2020 Phase-II clinical trials in Varicella zoster virus infections (Prevention. In children) in China (unspecified route) (ChiCTR2000034434)
  • 27 Jul 2010 WanTai Biopharmaceutical has a worldwide patent pending for Orf7 deficient varicella virus, vaccine comprising the virus and use thereof (WO2011011971A1)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top